Literature DB >> 28820329

Sources to variability in circulating human miRNA signatures.

Andreas Keller1, Trine Rounge2, Christina Backes1, Nicole Ludwig3, Randi Gislefoss2, Petra Leidinger3, Hilde Langseth2, Eckart Meese3.   

Abstract

An increasing number of studies propose circulating microRNAs (miRNAs) as biomarkers for a large number of human diseases including cancer, cardiovascular diseases, neurologic pathologies and others. To further validate miRNA as biomarkers it is indispensable to understand the variability of circulating miRNAs in healthy individuals. We determined the longitudinal miRNomes of 90 serum samples from the Janus Serum Bank in Norway, which have been stored between 23 and 40 y at -25 °Celsius. We profiled 3 serum samples with microarrays for 30 individuals, each. For each individual the samples were collected with a time interval of approximately 5 y. This design allowed insights into inter-individual variability, age dependent miRNA variability and the impact of storage length and pre-processing. A significant proportion of the miRNome was affected by the age of the blood donor and a not negligible, albeit small, part of the miRNome by the storage time. A substantial part of miRNAs was differentially abundant between individuals, independent of the time when samples were collected. Stepwise filtering of the 529 miRNAs that were detected in the serum samples showed 168 miRNAs with differential abundance depending on the time point analyzed, 56 miRNAs differentially abundant between individuals, and 169 miRNAs with an abundance depending on the sampling procedure. While these groups of miRNAs contain generally interesting and biologically important miRNAs, the remaining 135 miRNAs constitute very promising biomarker candidates as they show an overall low variability between healthy individuals, a likewise overall low variability across a longer life span, and a high independence of the sampling process and the storage length.

Entities:  

Keywords:  circulating biomarkers; control signatures; miRNA; serum

Mesh:

Substances:

Year:  2017        PMID: 28820329      PMCID: PMC5731815          DOI: 10.1080/15476286.2017.1367888

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  32 in total

1.  MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome.

Authors:  Marc K Halushka
Journal:  J Heart Lung Transplant       Date:  2016-01-14       Impact factor: 10.247

2.  Deep characterization of blood cell miRNomes by NGS.

Authors:  Eva C Schwarz; Christina Backes; Arne Knörck; Nicole Ludwig; Petra Leidinger; Cora Hoxha; Gertrud Schwär; Thomas Grossmann; Sabine C Müller; Martin Hart; Jan Haas; Valentina Galata; Isabelle Müller; Tobias Fehlmann; Hermann Eichler; Andre Franke; Benjamin Meder; Eckart Meese; Markus Hoth; Andreas Keller
Journal:  Cell Mol Life Sci       Date:  2016-02-13       Impact factor: 9.261

3.  Toward the blood-borne miRNome of human diseases.

Authors:  Andreas Keller; Petra Leidinger; Andrea Bauer; Abdou Elsharawy; Jan Haas; Christina Backes; Anke Wendschlag; Nathalia Giese; Christine Tjaden; Katja Ott; Jens Werner; Thilo Hackert; Klemens Ruprecht; Hanno Huwer; Junko Huebers; Gunnar Jacobs; Philip Rosenstiel; Henrik Dommisch; Arne Schaefer; Joachim Müller-Quernheim; Bernd Wullich; Bastian Keck; Norbert Graf; Joerg Reichrath; Britta Vogel; Almut Nebel; Sven U Jager; Peer Staehler; Ioannis Amarantos; Valesca Boisguerin; Cord Staehler; Markus Beier; Matthias Scheffler; Markus W Büchler; Joerg Wischhusen; Sebastian F M Haeusler; Johannes Dietl; Sylvia Hofmann; Hans-Peter Lenhof; Stefan Schreiber; Hugo A Katus; Wolfgang Rottbauer; Benjamin Meder; Joerg D Hoheisel; Andre Franke; Eckart Meese
Journal:  Nat Methods       Date:  2011-09-04       Impact factor: 28.547

4.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

5.  Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study.

Authors:  Pieter Mestdagh; Nicole Hartmann; Lukas Baeriswyl; Ditte Andreasen; Nathalie Bernard; Caifu Chen; David Cheo; Petula D'Andrade; Mike DeMayo; Lucas Dennis; Stefaan Derveaux; Yun Feng; Stephanie Fulmer-Smentek; Bernhard Gerstmayer; Julia Gouffon; Chris Grimley; Eric Lader; Kathy Y Lee; Shujun Luo; Peter Mouritzen; Aishwarya Narayanan; Sunali Patel; Sabine Peiffer; Silvia Rüberg; Gary Schroth; Dave Schuster; Jonathan M Shaffer; Elliot J Shelton; Scott Silveria; Umberto Ulmanella; Vamsi Veeramachaneni; Frank Staedtler; Thomas Peters; Toumy Guettouche; Linda Wong; Jo Vandesompele
Journal:  Nat Methods       Date:  2014-06-29       Impact factor: 28.547

6.  Influence of the confounding factors age and sex on microRNA profiles from peripheral blood.

Authors:  Benjamin Meder; Christina Backes; Jan Haas; Petra Leidinger; Cord Stähler; Thomas Großmann; Britta Vogel; Karen Frese; Evangelos Giannitsis; Hugo A Katus; Eckart Meese; Andreas Keller
Journal:  Clin Chem       Date:  2014-06-30       Impact factor: 8.327

7.  Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

Authors:  Andreas Keller; Petra Leidinger; Randi Gislefoss; Aage Haugen; Hilde Langseth; Peer Staehler; Hans-Peter Lenhof; Eckart Meese
Journal:  RNA Biol       Date:  2011-05-01       Impact factor: 4.652

8.  miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments.

Authors:  Andreas Keller; Petra Leidinger; Anne Borries; Anke Wendschlag; Frank Wucherpfennig; Matthias Scheffler; Hanno Huwer; Hans-Peter Lenhof; Eckart Meese
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

Review 9.  Methodological challenges in utilizing miRNAs as circulating biomarkers.

Authors:  Leni Moldovan; Kara E Batte; Joanne Trgovcich; Jon Wisler; Clay B Marsh; Melissa Piper
Journal:  J Cell Mol Med       Date:  2014-02-18       Impact factor: 5.310

10.  High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Authors:  Petra Leidinger; Thomas Brefort; Christina Backes; Medea Krapp; Valentina Galata; Markus Beier; Jochen Kohlhaas; Hanno Huwer; Eckart Meese; Andreas Keller
Journal:  Oncotarget       Date:  2016-01-26
View more
  14 in total

1.  Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis.

Authors:  Andreas Keller; Tobias Fehlmann; Christina Backes; Fabian Kern; Randi Gislefoss; Hilde Langseth; Trine B Rounge; Nicole Ludwig; Eckart Meese
Journal:  RNA Biol       Date:  2020-06-16       Impact factor: 4.652

2.  Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury.

Authors:  Francesca Polito; Fausto Famà; Rosaria Oteri; Giovanni Raffa; Gianluca Vita; Alfredo Conti; Sacco Daniele; Vincenzo Macaione; Marcello Passalacqua; Salvatore Cardali; Rosa Maria Di Giorgio; Maria Gioffrè; Flavio F Angileri; Antonino Germanò; M'Hammed Aguennouz
Journal:  Mol Biol Rep       Date:  2020-03-26       Impact factor: 2.316

3.  Variability of multi-omics profiles in a population-based child cohort.

Authors:  Marta Gallego-Paüls; Carles Hernández-Ferrer; Mariona Bustamante; Xavier Basagaña; Jose Barrera-Gómez; Chung-Ho E Lau; Alexandros P Siskos; Marta Vives-Usano; Carlos Ruiz-Arenas; John Wright; Remy Slama; Barbara Heude; Maribel Casas; Regina Grazuleviciene; Leda Chatzi; Eva Borràs; Eduard Sabidó; Ángel Carracedo; Xavier Estivill; Jose Urquiza; Muireann Coen; Hector C Keun; Juan R González; Martine Vrijheid; Léa Maitre
Journal:  BMC Med       Date:  2021-07-22       Impact factor: 8.775

4.  Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity.

Authors:  Trine B Rounge; Sinan U Umu; Andreas Keller; Eckart Meese; Giske Ursin; Steinar Tretli; Robert Lyle; Hilde Langseth
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

5.  Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies.

Authors:  Aoife Ward Gahlawat; Judith Lenhardt; Tania Witte; Denise Keitel; Anna Kaufhold; Kendra K Maass; Kristian W Pajtler; Christof Sohn; Sarah Schott
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

6.  Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation.

Authors:  Hui Qin; Dong-Yue Wen; Qiao Que; Chuan-Yang Zhou; Xiao-Dong Wang; Yu-Ting Peng; Yun He; Hong Yang; Bo-Ming Liao
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

7.  A comprehensive profile of circulating RNAs in human serum.

Authors:  Sinan Uğur Umu; Hilde Langseth; Cecilie Bucher-Johannessen; Bastian Fromm; Andreas Keller; Eckart Meese; Marianne Lauritzen; Magnus Leithaug; Robert Lyle; Trine B Rounge
Journal:  RNA Biol       Date:  2017-12-08       Impact factor: 4.652

8.  Single-Nucleotide Polymorphisms in XPO5 are Associated with Noise-Induced Hearing Loss in a Chinese Population.

Authors:  Ning Wang; Boshen Wang; Jiadi Guo; Suhao Zhang; Lei Han; Juan Zhang; Baoli Zhu
Journal:  Biochem Res Int       Date:  2020-02-17

9.  A Comprehensive Analysis of MicroRNAs in Human Osteoporosis.

Authors:  Ying Huai; Wenjuan Zhang; Zhihao Chen; Fan Zhao; Wei Wang; Kai Dang; Kaiyue Xue; Yongguang Gao; Shanfeng Jiang; Zhiping Miao; Meng Li; Qiang Hao; Chu Chen; Airong Qian
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-21       Impact factor: 5.555

Review 10.  Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.

Authors:  Sujay Paul; Luis Alberto Bravo Vázquez; Samantha Pérez Uribe; Paula Roxana Reyes-Pérez; Ashutosh Sharma
Journal:  Cells       Date:  2020-07-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.